IV Dressing Market To Reach $1.21 Billion By 2030 | CAGR: 5.50%

IV Dressing Market Growth & Trends

The global IV dressing market size is anticipated to reach USD 1.21 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 5.50% from 2024 to 2030. Increasing cases of blood infections, such as CLABSI and CRBSI, and a rising number of hospital admissions are likely to boost market demand. Also, the rising geriatric population and increasing prevalence of chronic disorders are factors contributing to market growth. For instance, according to the WHO, between 2015 and 2050, the proportion of geriatric population is expected to double from 12% to 22%, making old age a significant risk factor for developing chronic disorders. A rise in awareness and adoption of IV therapy for treating various chronic diseases including cancer is anticipated to drive market growth. Various players are launching novel IV therapies.

For instance, in January 2023, Glenmark Pharmaceuticals Ltd. launched the IV infection formulation AKYNZEO IV in India to prevent chemotherapy-induced vomiting and nausea. Strategic initiatives undertaken by top players, such as acquisitions, are expected to contribute to market growth. For instance, in September 2022, B. Braun Medical Inc. acquired catheter securement products from Starboard Medical. This initiative was anticipated to improve patient care and extend the company’s IV therapy offering including IV dressing. Furthermore, geographical expansion activities by key players are projected to boost market growth. For instance, in January 2022, Smith+Nephew inaugurated a new commercial hub to increase the company’s product offerings in the Nordic region.

 Request a free sample copy or view report summary: IV Dressing Market Report

IV Dressing Market Report Highlights

• The transparent product segment accounted for the largest market share in 2023 and is expected to grow at the fastest CAGR of 5.71% from 2024 to 2030

• This is owing to the introduction of a novel transparent film dressing with a chlorhexidine gluconate-impregnated gelpatch to offer ongoing disinfection of the site throughout the duration of the catheter

• The hospitals end-use segment held the largest revenue share of 45.39% in 2023 owing to the high healthcare investments, a rise in the number of hospitalizations, and incidences of infectious & chronic diseases

• North America captured the largest revenue share of 45.46% in 2023. This is owing to the well-developed healthcare infrastructure, high geriatric population, and rise in the awareness & adoption of IV therapies

IV Dressing Market Segmentation

Grand View Research has segmented the global IV dressing market on the basis of type, end-use, and region:

IV Dressing Type Outlook (Revenue, USD Million, 2018 - 2030)

• Translucent

• Transparent

IV Dressing End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Clinics

• Others

IV Dressing Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of IV Dressing Market

• 3M

• Smith+Nephew

• Cardinal Health

• McKesson Corporation

• Covalon Technologies Ltd.

• Richardson Healthcare, Inc.

• Medline Industries

• Paul Hartmann AG

• Lohmann & Rauscher (L&R)

• Mölnlycke Health Care AB

• DermaRite Industries, LLC

• Bsn Medical

• DeRoyal Industries, Inc.

• Dynarex Corporation

• Komal Health Care Pvt. Ltd.

• Sentry Medical

• Shandong Dermcosy Medical Co., Ltd.